Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial

ConclusionA tailored DXA result letter and educational brochure failed to improve guideline-concordant care in patients who received DXA.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research